Pneumocystis Jiroveci Pneumonia Latest Advances

Resistance Patterns and Optimization of Empirical Therapy for Urinary Tract Infections in Patients on Trimethoprim-Sulfamethoxazole Prophylaxis Against Pneumocystis jirovecii.

Journal: Microbial drug resistance (Larchmont, N.Y.)

Published: October 17, 2025

Unmasking MHC Class II Deficiency: A Novel Mutation in a Child with Pediatric ARDS due to Pneumocystis Jirovecii Pneumonia.

Journal: EJIFCC

Published: October 16, 2025

Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: October 14, 2025

An infant with leukemia complicated by Pneumocystisjirovecii pneumonia: A case report and literature review

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: September 27, 2025

Evaluation and Clinical Impact of the Combination of Wako® (1,3)-β-D-Glucan in Serum and RT-PCR in Oral Wash for Pneumocystis jirovecii Infection Diagnosis: A Retrospective Cohort Study.

Journal: Medical mycology

Published: September 19, 2025

Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques.

Journal: Medical mycology

Published: September 19, 2025

Pneumocystis jirovecii Pneumonia in Patients Without HIV, Transplant, or Cancer: Missed Opportunities for Prevention.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: September 16, 2025

Beginning of ABO-Incompatible Transplants in Pakistan: A Single-Centre Experience.

Journal: Cureus

Published: September 08, 2025

When Trimethoprim-Sulfamethoxazole Turns Pernicious: Type 4 Renal Tubular Acidosis in a Diabetic Patient With Sjögren's Syndrome.

Journal: Cureus

Published: September 04, 2025

Population pharmacokinetics and Monte Carlo-based dosing optimization of trimethoprim-sulfamethoxazole.

Journal: Antimicrobial agents and chemotherapy

Published: September 03, 2025

Pneumocystis pneumonia in thoracic organ transplantation: Current perspectives and updates.

Journal: JHLT open

Published: September 02, 2025

The impact of the SARS-CoV-2 pandemic on the development of respiratory infections caused by Aspergillus spp., Mucor spp., and Pneumocystis jirovecii within the National Health System of Spain.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 28, 2025

Filters

Resistance Patterns and Optimization of Empirical Therapy for Urinary Tract Infections in Patients on Trimethoprim-Sulfamethoxazole Prophylaxis Against Pneumocystis jirovecii.

Resistance Patterns and Optimization of Empirical Therapy for Urinary Tract Infections in Patients on Trimethoprim-Sulfamethoxazole Prophylaxis Against Pneumocystis jirovecii.

Unmasking MHC Class II Deficiency: A Novel Mutation in a Child with Pediatric ARDS due to Pneumocystis Jirovecii Pneumonia.

Unmasking MHC Class II Deficiency: A Novel Mutation in a Child with Pediatric ARDS due to Pneumocystis Jirovecii Pneumonia.

Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients.

Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients.

An infant with leukemia complicated by Pneumocystisjirovecii pneumonia: A case report and literature review

An infant with leukemia complicated by Pneumocystisjirovecii pneumonia: A case report and literature review

Evaluation and Clinical Impact of the Combination of Wako® (1,3)-β-D-Glucan in Serum and RT-PCR in Oral Wash for Pneumocystis jirovecii Infection Diagnosis: A Retrospective Cohort Study.

Evaluation and Clinical Impact of the Combination of Wako® (1,3)-β-D-Glucan in Serum and RT-PCR in Oral Wash for Pneumocystis jirovecii Infection Diagnosis: A Retrospective Cohort Study.

Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques.

Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques.

Pneumocystis jirovecii Pneumonia in Patients Without HIV, Transplant, or Cancer: Missed Opportunities for Prevention.

Pneumocystis jirovecii Pneumonia in Patients Without HIV, Transplant, or Cancer: Missed Opportunities for Prevention.

Beginning of ABO-Incompatible Transplants in Pakistan: A Single-Centre Experience.

Beginning of ABO-Incompatible Transplants in Pakistan: A Single-Centre Experience.

When Trimethoprim-Sulfamethoxazole Turns Pernicious: Type 4 Renal Tubular Acidosis in a Diabetic Patient With Sjögren's Syndrome.

When Trimethoprim-Sulfamethoxazole Turns Pernicious: Type 4 Renal Tubular Acidosis in a Diabetic Patient With Sjögren's Syndrome.

Population pharmacokinetics and Monte Carlo-based dosing optimization of trimethoprim-sulfamethoxazole.

Population pharmacokinetics and Monte Carlo-based dosing optimization of trimethoprim-sulfamethoxazole.

Pneumocystis pneumonia in thoracic organ transplantation: Current perspectives and updates.

Pneumocystis pneumonia in thoracic organ transplantation: Current perspectives and updates.

The impact of the SARS-CoV-2 pandemic on the development of respiratory infections caused by Aspergillus spp., Mucor spp., and Pneumocystis jirovecii within the National Health System of Spain.

The impact of the SARS-CoV-2 pandemic on the development of respiratory infections caused by Aspergillus spp., Mucor spp., and Pneumocystis jirovecii within the National Health System of Spain.